{
  "retracted": false,
  "timestamp": 1499212800000,
  "updates": [
    {
      "timestamp": 1566585615549,
      "identifier": {
        "doi": "10.1007/s10637-017-0479-3"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1007/s10637-017-0459-7"
  },
  "journal": "Investigational New Drugs",
  "publisher": "Springer Science and Business Media LLC",
  "title": "Erratum to: A phase I dose-escalation study of Selumetinib in combination with Erlotinib or Temsirolimus in patients with advanced solid tumors"
}
